SUBHASH C PROOTHI MD
Prescription History 1376537621
Internal Medicine - Hematology & Oncology in Fountain Hill, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SUBHASH C PROOTHI MD, an active Hematology & Oncology specialist practicing in Fountain Hill, PA. Our medical registry currently tracks 39 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,724 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 143 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| EliquisApixaban | 143 | $878.40 | ▲ More than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 143 Medicare prescriptions for Eliquis, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (92). Medicare paid an average of $878.40 per fill, versus $730.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 225.5 30-Day Fills standardized to 30-day supplies 6,705 Days of Medication total across all patients in 2023 | |||
| Letrozole | 133 | $26.58▼ below PA avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 133 Medicare prescriptions for Letrozole, about 2.9 times the volume of the typical Pennsylvania prescriber of this medication (46). Medicare paid an average of $26.58 per fill, versus $26.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 315 30-Day Fills standardized to 30-day supplies 9,426 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 120 | $19.78▼ below PA avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 120 Medicare prescriptions for Acyclovir, about 4.4 times the volume of the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $19.78 per fill, versus $26.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 203 30-Day Fills standardized to 30-day supplies 6,008 Days of Medication total across all patients in 2023 | |||
| Prednisone | 112 | $9.64 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 112 Medicare prescriptions for Prednisone, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $9.64 per fill, versus $5.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 169.6 30-Day Fills standardized to 30-day supplies 4,984 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 103 | $11.60▼ below PA avg | ▲ More than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 103 Medicare prescriptions for Allopurinol, about 2.1 times the volume of the typical Pennsylvania prescriber of this medication (50). Medicare paid an average of $11.60 per fill, versus $14.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 218 30-Day Fills standardized to 30-day supplies 6,492 Days of Medication total across all patients in 2023 | |||
| Ondansetron Hcl | 95 | $7.19▼ below PA avg | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 95 Medicare prescriptions for Ondansetron Hcl, about 3.7 times the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $7.19 per fill, versus $15.25 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 98 30-Day Fills standardized to 30-day supplies 859 Days of Medication total across all patients in 2023 | |||
| Abiraterone Acetate | 75 | $2,739.32▼ below PA avg | ▲ More than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 75 Medicare prescriptions for Abiraterone Acetate, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (40). Medicare paid an average of $2,739.32 per fill, versus $3,499.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 83 30-Day Fills standardized to 30-day supplies 2,490 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 74 | $24.67▼ below PA avg | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 74 Medicare prescriptions for Hydroxyurea, about 2.2 times the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $24.67 per fill, versus $33.87 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 142 30-Day Fills standardized to 30-day supplies 4,236 Days of Medication total across all patients in 2023 | |||
| Potassium Chloride | 73 | $17.86▼ below PA avg | ≈ Typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2023, this provider wrote 73 Medicare prescriptions for Potassium Chloride, about the same volume as the typical Pennsylvania prescriber of this medication (70). Medicare paid an average of $17.86 per fill, versus $30.86 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 75 30-Day Fills standardized to 30-day supplies 1,879 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 54 | $17.91 | ▲ More than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 54 Medicare prescriptions for Dexamethasone, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $17.91 per fill, versus $16.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 67.2 30-Day Fills standardized to 30-day supplies 1,760 Days of Medication total across all patients in 2023 | |||
| CalquenceAcalabrutinib Maleate | 52 | $13,539.72▼ below PA avg | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 52 Medicare prescriptions for Calquence, about 2.5 times the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $13,539.72 per fill, versus $14,167.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 52 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2023 | |||
| Anastrozole | 42 | $33.44 | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 42 Medicare prescriptions for Anastrozole, about 61% of the volume of the typical Pennsylvania prescriber of this medication (69). Medicare paid an average of $33.44 per fill, versus $27.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 120 30-Day Fills standardized to 30-day supplies 3,600 Days of Medication total across all patients in 2023 | |||
| Lorazepam | 41 | $6.45▼ below PA avg | ▼ Less than typical |
About Lorazepam: This medication is used to treat serious seizures that do not stop (status epilepticus). Show more ▾ It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain. A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2023, this provider wrote 41 Medicare prescriptions for Lorazepam, about 65% of the volume of the typical Pennsylvania prescriber of this medication (63). Medicare paid an average of $6.45 per fill, versus $7.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 49 30-Day Fills standardized to 30-day supplies 1,391 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 39 | $12.73▼ below PA avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 39 Medicare prescriptions for Levothyroxine Sodium, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (171). Medicare paid an average of $12.73 per fill, versus $16.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 65 30-Day Fills standardized to 30-day supplies 1,947 Days of Medication total across all patients in 2023 | |||
| BrukinsaZanubrutinib | 38 | $15,192.67 | ▲ More than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 38 Medicare prescriptions for Brukinsa, about 2 times the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $15,192.67 per fill, versus $12,611.25 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 33 | $22,163.19 | ≈ Typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 33 Medicare prescriptions for Revlimid, about the same volume as the typical Pennsylvania prescriber of this medication (35). Medicare paid an average of $22,163.19 per fill, versus $18,521.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 924 Days of Medication total across all patients in 2023 | |||
| Tamoxifen Citrate | 32 | $30.42▼ below PA avg | ≈ Typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 32 Medicare prescriptions for Tamoxifen Citrate, about the same volume as the typical Pennsylvania prescriber of this medication (32). Medicare paid an average of $30.42 per fill, versus $32.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 50 30-Day Fills standardized to 30-day supplies 1,498 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 32 | $8.97 | ≈ Typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 32 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $8.97 per fill, versus $5.26 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,057 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 32 | $1,190.06 | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 32 Medicare prescriptions for Xarelto, about 67% of the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,190.06 per fill, versus $800.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 70 30-Day Fills standardized to 30-day supplies 2,100 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 32 | $15,644.04 | ≈ Typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 32 Medicare prescriptions for Ibrance, about the same volume as the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $15,644.04 per fill, versus $14,656.09 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 896 Days of Medication total across all patients in 2023 | |||
| Pantoprazole Sodium | 31 | $14.24▼ below PA avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2023, this provider wrote 31 Medicare prescriptions for Pantoprazole Sodium, about a third of the volume of the typical Pennsylvania prescriber of this medication (96). Medicare paid an average of $14.24 per fill, versus $16.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| NinlaroIxazomib Citrate | 31 | $13,662.58 | ▲ More than typical |
About Ninlaro: This medication is used to treat a certain type of cancer (multiple myeloma). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 31 Medicare prescriptions for Ninlaro, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $13,662.58 per fill, versus $12,450.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 868 Days of Medication total across all patients in 2023 | |||
| Exemestane | 29 | $295.34 | ≈ Typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 29 Medicare prescriptions for Exemestane, about the same volume as the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $295.34 per fill, versus $258.43 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 61 30-Day Fills standardized to 30-day supplies 1,830 Days of Medication total across all patients in 2023 | |||
| Enoxaparin Sodium | 26 | $266.99 | ≈ Typical |
About Enoxaparin Sodium: Enoxaparin is used to prevent and treat harmful blood clots. Show more ▾ This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a blood thinner. It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other blood thinners. In 2023, this provider wrote 26 Medicare prescriptions for Enoxaparin Sodium, about the same volume as the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $266.99 per fill, versus $144.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 638 Days of Medication total across all patients in 2023 | |||
| Oxycodone Hcl | 23 | $7.21▼ below PA avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2023, this provider wrote 23 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical Pennsylvania prescriber of this medication (54). Medicare paid an average of $7.21 per fill, versus $22.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 23 30-Day Fills standardized to 30-day supplies 423 Days of Medication total across all patients in 2023 | |||
| SprycelDasatinib | 23 | $8,462.18▼ below PA avg | ▲ More than typical |
About Sprycel: This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. In 2023, this provider wrote 23 Medicare prescriptions for Sprycel, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $8,462.18 per fill, versus $13,106.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 23 | $16,128.44▼ below PA avg | ≈ Typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 23 Medicare prescriptions for Jakafi, about the same volume as the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $16,128.44 per fill, versus $16,359.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $15.49▼ below PA avg | ▼ Less than typical |
About Oxycodone-Acetaminophen: This combination medication is used to help relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2023, this provider wrote 22 Medicare prescriptions for Oxycodone-Acetaminophen, about half the volume of the typical Pennsylvania prescriber of this medication (52). Medicare paid an average of $15.49 per fill, versus $22.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 22 30-Day Fills standardized to 30-day supplies 438 Days of Medication total across all patients in 2023 | |||
| Furosemide | 21 | $4.25▼ below PA avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2023, this provider wrote 21 Medicare prescriptions for Furosemide, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (96). Medicare paid an average of $4.25 per fill, versus $5.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 17 | $16,769.25 | ≈ Typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 17 Medicare prescriptions for Lenalidomide, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (14). Medicare paid an average of $16,769.25 per fill, versus $15,213.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 469 Days of Medication total across all patients in 2023 | |||
| Bicalutamide | 17 | $43.80 | ▼ Less than typical |
About Bicalutamide: Bicalutamide is used to treat prostate cancer. Show more ▾ This medication works by blocking the action of male hormones in the prostate, slowing the growth of cancer cells. This medication should not be used in women and children. In 2023, this provider wrote 17 Medicare prescriptions for Bicalutamide, about 71% of the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $43.80 per fill, versus $35.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| Alprazolam | 17 | $9.43▼ below PA avg | ▼ Less than typical |
About Alprazolam: Alprazolam is used to treat anxiety and panic disorders. Show more ▾ It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA). A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) In 2023, this provider wrote 17 Medicare prescriptions for Alprazolam, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (67). Medicare paid an average of $9.43 per fill, versus $10.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 23 30-Day Fills standardized to 30-day supplies 523 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 16 | $14,477.28▼ below PA avg | ▼ Less than typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 16 Medicare prescriptions for Imbruvica, about half the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $14,477.28 per fill, versus $14,546.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 16 30-Day Fills standardized to 30-day supplies 458 Days of Medication total across all patients in 2023 | |||
| VenclextaVenetoclax | 14 | $3,389.83▼ below PA avg | ▼ Less than typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. In 2023, this provider wrote 14 Medicare prescriptions for Venclexta, about half the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $3,389.83 per fill, versus $8,816.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 14 30-Day Fills standardized to 30-day supplies 396 Days of Medication total across all patients in 2023 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $18.67▼ below PA avg | ▼ Less than typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2023, this provider wrote 13 Medicare prescriptions for Lidocaine-Prilocaine, about 62% of the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $18.67 per fill, versus $28.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 13 30-Day Fills standardized to 30-day supplies 289 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 12 | $305.65▼ below PA avg | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 12 Medicare prescriptions for Imatinib Mesylate, about half the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $305.65 per fill, versus $2,955.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| JantovenWarfarin Sodium | 12 | $6.34▼ below PA avg | ▼ Less than typical |
About Jantoven: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a blood thinner, but the more correct term is anticoagulant. It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2023, this provider wrote 12 Medicare prescriptions for Jantoven, about half the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $6.34 per fill, versus $11.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| Famotidine | 11 | $10.09▼ below PA avg | ▼ Less than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2023, this provider wrote 11 Medicare prescriptions for Famotidine, about a third of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $10.09 per fill, versus $10.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 24.6 30-Day Fills standardized to 30-day supplies 693 Days of Medication total across all patients in 2023 | |||
| Warfarin Sodium | 11 | $16.64 | ▼ Less than typical |
About Warfarin Sodium: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a blood thinner, but the more correct term is anticoagulant. It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2023, this provider wrote 11 Medicare prescriptions for Warfarin Sodium, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (53). Medicare paid an average of $16.64 per fill, versus $12.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.4 30-Day Fills standardized to 30-day supplies 670 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for SUBHASH C PROOTHI MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Fountain Hill, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
